logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11874276 B1

PDFFull Text
Date of Patent:
Jan. 16, 2024

Filed:

Apr. 05, 2019

Sting levels as a biomarker for cancer immunotherapy

Applicants:

Dana-farber Cancer Institute, Inc., Boston, MA (US);

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Inventors:

David Barbie, Andover, MA (US);

Israel Cañadas, Brookline, MA (US);

Shunsuke Kitajima, Allston, MA (US);

Thanh Barbie, Andover, MA (US);

Assignees:

Dana-Farber Cancer Institute, Inc., Boston, MA (US);

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Attorney:

Wolf, Greenfield & Sacks, P.C.

Primary Examiner:

Brian Gangle

Assistant Examiner:

Andrea K McCollum

Int. Cl.
CPC ...
G01N 33/574 (2006.01); A61K 38/00 (2006.01); A61K 38/21 (2006.01); A61P 35/00 (2006.01); C07K 14/05 (2006.01); G01N 33/68 (2006.01); C07K 14/57 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57484 (2013.01); A61K 38/005 (2013.01); A61K 38/21 (2013.01); A61K 38/217 (2013.01); A61P 35/00 (2018.01); C07K 14/57 (2013.01); G01N 33/57423 (2013.01); G01N 33/6866 (2013.01); G01N 2800/52 (2013.01);
Abstract

Provided herein are Stimulator of Interferon Genes (STING) and Stimulated 3 Prime Antisense Retroviral Coding Sequences (SPARCS) genes as biomarkers for determining an effective therapy for treating cancer. Further provided are methods for treating cancer using said biomarkers.

Find Patent Forward Citations

Barbie, David. (2024). Sting levels as a biomarker for cancer immunotherapy (U.S. Patent No. 11874276). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11874276

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…